244 related articles for article (PubMed ID: 33315115)
1. Assessment of Time-to-Treatment Initiation and Survival in a Cohort of Patients With Common Cancers.
Cone EB; Marchese M; Paciotti M; Nguyen DD; Nabi J; Cole AP; Molina G; Molina RL; Minami CA; Mucci LA; Kibel AS; Trinh QD
JAMA Netw Open; 2020 Dec; 3(12):e2030072. PubMed ID: 33315115
[TBL] [Abstract][Full Text] [Related]
2. Time to initial cancer treatment in the United States and association with survival over time: An observational study.
Khorana AA; Tullio K; Elson P; Pennell NA; Grobmyer SR; Kalady MF; Raymond D; Abraham J; Klein EA; Walsh RM; Monteleone EE; Wei W; Hobbs B; Bolwell BJ
PLoS One; 2019; 14(3):e0213209. PubMed ID: 30822350
[TBL] [Abstract][Full Text] [Related]
3. The Effects of Time to Treatment Initiation for Patients With Non-small-cell Lung Cancer in the United States.
Cushman TR; Jones B; Akhavan D; Rusthoven CG; Verma V; Salgia R; Sedrak M; Massarelli E; Welsh JW; Amini A
Clin Lung Cancer; 2021 Jan; 22(1):e84-e97. PubMed ID: 33039348
[TBL] [Abstract][Full Text] [Related]
4. Effect of Medicaid Expansion on Receipt of Definitive Treatment and Time to Treatment Initiation by Racial and Ethnic Minorities and at Minority-Serving Hospitals: A Patient-Level and Facility-Level Analysis of Breast, Colon, Lung, and Prostate Cancer.
Nguyen DD; Paciotti M; Marchese M; Cole AP; Cone EB; Kibel AS; Ortega G; Lipsitz SR; Weissman JS; Trinh QD
JCO Oncol Pract; 2021 May; 17(5):e654-e665. PubMed ID: 33974827
[TBL] [Abstract][Full Text] [Related]
5. Trends in Patient Volume by Hospital Type and the Association of These Trends With Time to Cancer Treatment Initiation.
Frosch ZAK; Illenberger N; Mitra N; Boffa DJ; Facktor MA; Nelson H; Palis BE; Bekelman JE; Shulman LN; Takvorian SU
JAMA Netw Open; 2021 Jul; 4(7):e2115675. PubMed ID: 34241630
[TBL] [Abstract][Full Text] [Related]
6. Predictive Factors for Cancer Treatment Delay in a Racially Diverse and Socioeconomically Disadvantaged Urban Population.
Sheni R; Qin J; Viswanathan S; Castellucci E; Kalnicki S; Mehta V
JCO Oncol Pract; 2023 Jun; 19(6):e904-e915. PubMed ID: 37001038
[TBL] [Abstract][Full Text] [Related]
7. Increased pathologic upstaging with rising time to treatment initiation for head and neck cancer: A mechanism for increased mortality.
Xiao R; Ward MC; Yang K; Adelstein DJ; Koyfman SA; Prendes BL; Burkey BB
Cancer; 2018 Apr; 124(7):1400-1414. PubMed ID: 29315499
[TBL] [Abstract][Full Text] [Related]
8. A systematic review and meta-analysis of surgery delays and survival in breast, lung and colon cancers: Implication for surgical triage during the COVID-19 pandemic.
Johnson BA; Waddimba AC; Ogola GO; Fleshman JW; Preskitt JT
Am J Surg; 2021 Aug; 222(2):311-318. PubMed ID: 33317814
[TBL] [Abstract][Full Text] [Related]
9. Neighborhood and Individual Socioeconomic Disadvantage and Survival Among Patients With Nonmetastatic Common Cancers.
Cheng E; Soulos PR; Irwin ML; Cespedes Feliciano EM; Presley CJ; Fuchs CS; Meyerhardt JA; Gross CP
JAMA Netw Open; 2021 Dec; 4(12):e2139593. PubMed ID: 34919133
[TBL] [Abstract][Full Text] [Related]
10. Guideline-concordant cancer care and survival among American Indian/Alaskan Native patients.
Javid SH; Varghese TK; Morris AM; Porter MP; He H; Buchwald D; Flum DR;
Cancer; 2014 Jul; 120(14):2183-90. PubMed ID: 24711210
[TBL] [Abstract][Full Text] [Related]
11. Real world duration of curative intent breast, colorectal, non-small cell lung, and prostate cancer treatment.
Wong SK; Hamm J; Shokoohi A; McGahan CE; Ho C
BMC Cancer; 2021 Mar; 21(1):215. PubMed ID: 33653306
[TBL] [Abstract][Full Text] [Related]
12. Development and Validation of a Clinical Prognostic Stage Group System for Nonmetastatic Prostate Cancer Using Disease-Specific Mortality Results From the International Staging Collaboration for Cancer of the Prostate.
Dess RT; Suresh K; Zelefsky MJ; Freedland SJ; Mahal BA; Cooperberg MR; Davis BJ; Horwitz EM; Terris MK; Amling CL; Aronson WJ; Kane CJ; Jackson WC; Hearn JWD; Deville C; DeWeese TL; Greco S; McNutt TR; Song DY; Sun Y; Mehra R; Kaffenberger SD; Morgan TM; Nguyen PL; Feng FY; Sharma V; Tran PT; Stish BJ; Pisansky TM; Zaorsky NG; Moraes FY; Berlin A; Finelli A; Fossati N; Gandaglia G; Briganti A; Carroll PR; Karnes RJ; Kattan MW; Schipper MJ; Spratt DE
JAMA Oncol; 2020 Dec; 6(12):1912-1920. PubMed ID: 33090219
[TBL] [Abstract][Full Text] [Related]
13. Development and Validation of a Prognostic Survival Model With Patient-Reported Outcomes for Patients With Cancer.
Seow H; Tanuseputro P; Barbera L; Earle C; Guthrie D; Isenberg S; Juergens R; Myers J; Brouwers M; Sutradhar R
JAMA Netw Open; 2020 Apr; 3(4):e201768. PubMed ID: 32236529
[TBL] [Abstract][Full Text] [Related]
14. Association of Adjuvant Hormone Therapy Timing With Overall Survival Among Patients With Hormone Receptor-Positive Human Epidermal Growth Factor Receptor-2-Negative Early Breast Cancer Without Chemotherapy.
Fu F; Yu L; Zeng B; Chen M; Guo W; Chen L; Lin Y; Hou J; Li J; Li Y; Li S; Chen X; Zhang W; Jin X; Cai W; Zhang K; Chen H; Qiu Y; Nie Q; Wang C; Jacobs L
JAMA Netw Open; 2022 Feb; 5(2):e2145934. PubMed ID: 35166783
[TBL] [Abstract][Full Text] [Related]
15. Analysis of Delayed Surgical Treatment and Oncologic Outcomes in Clinical Stage I Non-Small Cell Lung Cancer.
Heiden BT; Eaton DB; Engelhardt KE; Chang SH; Yan Y; Patel MR; Kreisel D; Nava RG; Meyers BF; Kozower BD; Puri V
JAMA Netw Open; 2021 May; 4(5):e2111613. PubMed ID: 34042991
[TBL] [Abstract][Full Text] [Related]
16. Increasing time to treatment initiation for head and neck cancer: an analysis of the National Cancer Database.
Murphy CT; Galloway TJ; Handorf EA; Wang L; Mehra R; Flieder DB; Ridge JA
Cancer; 2015 Apr; 121(8):1204-13. PubMed ID: 25490875
[TBL] [Abstract][Full Text] [Related]
17. Impact of socioeconomic status on cancer incidence and stage at diagnosis: selected findings from the surveillance, epidemiology, and end results: National Longitudinal Mortality Study.
Clegg LX; Reichman ME; Miller BA; Hankey BF; Singh GK; Lin YD; Goodman MT; Lynch CF; Schwartz SM; Chen VW; Bernstein L; Gomez SL; Graff JJ; Lin CC; Johnson NJ; Edwards BK
Cancer Causes Control; 2009 May; 20(4):417-35. PubMed ID: 19002764
[TBL] [Abstract][Full Text] [Related]
18. How Soon Should Patients With Colon Cancer Undergo Definitive Resection?
Kucejko RJ; Holleran TJ; Stein DE; Poggio JL
Dis Colon Rectum; 2020 Feb; 63(2):172-182. PubMed ID: 31764246
[TBL] [Abstract][Full Text] [Related]
19. Racial disparities in cancer survival among randomized clinical trials patients of the Southwest Oncology Group.
Albain KS; Unger JM; Crowley JJ; Coltman CA; Hershman DL
J Natl Cancer Inst; 2009 Jul; 101(14):984-92. PubMed ID: 19584328
[TBL] [Abstract][Full Text] [Related]
20. Delays in definitive cervical cancer treatment: An analysis of disparities and overall survival impact.
Ramey SJ; Asher D; Kwon D; Ahmed AA; Wolfson AH; Yechieli R; Portelance L
Gynecol Oncol; 2018 Apr; 149(1):53-62. PubMed ID: 29605051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]